These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23468488)

  • 1. HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.
    Rolland M; Manocheewa S; Swain JV; Lanxon-Cookson EC; Kim M; Westfall DH; Larsen BB; Gilbert PB; Mullins JI
    J Virol; 2013 May; 87(10):5461-7. PubMed ID: 23468488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds.
    Liu Y; Rao U; McClure J; Konopa P; Manocheewa S; Kim M; Chen L; Troyer RM; Tebit DM; Holte S; Arts EJ; Mullins JI
    PLoS One; 2014; 9(4):e94240. PubMed ID: 24713822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.
    Chopera DR; Cotton LA; Zawaira A; Mann JK; Ngandu NK; Ntale R; Carlson JM; Mlisana K; Woodman Z; de Assis Rosa D; Martin E; Miura T; Pereyra F; Walker BD; Gray CM; Martin DP; Ndung'u T; Brockman MA; Karim SA; Brumme ZL; Williamson C;
    J Virol; 2012 Dec; 86(24):13423-33. PubMed ID: 23015721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite Sequence-Structure Stability Models as Screening Tools for Identifying Vulnerable Targets for HIV Drug and Vaccine Development.
    Manocheewa S; Mittler JE; Samudrala R; Mullins JI
    Viruses; 2015 Nov; 7(11):5718-35. PubMed ID: 26556362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
    Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.
    Rolland M; Jensen MA; Nickle DC; Yan J; Learn GH; Heath L; Weiner D; Mullins JI
    J Virol; 2007 Aug; 81(16):8507-14. PubMed ID: 17537854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosscurrents in HIV-1 evolution.
    Blankson JN; Bailey JR; Siliciano RF
    Nat Immunol; 2006 Feb; 7(2):121-2. PubMed ID: 16424885
    [No Abstract]   [Full Text] [Related]  

  • 14. Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.
    Kinloch NN; Lee GQ; Carlson JM; Jin SW; Brumme CJ; Byakwaga H; Muzoora C; Bwana MB; Cobarrubias KD; Hunt PW; Martin JN; Carrington M; Bangsberg DR; Harrigan PR; Brockman MA; Brumme ZL
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
    Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
    Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
    Mostowy R; Kouyos RD; Hoof I; Hinkley T; Haddad M; Whitcomb JM; Petropoulos CJ; Keşmir C; Bonhoeffer S
    PLoS Comput Biol; 2012; 8(5):e1002525. PubMed ID: 22654656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.
    Liu D; Zuo T; Hora B; Song H; Kong W; Yu X; Goonetilleke N; Bhattacharya T; Perelson AS; Haynes BF; McMichael AJ; Gao F
    Retrovirology; 2014 Nov; 11():101. PubMed ID: 25407514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.
    Ferguson AL; Mann JK; Omarjee S; Ndung'u T; Walker BD; Chakraborty AK
    Immunity; 2013 Mar; 38(3):606-17. PubMed ID: 23521886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.